用stearyl amine修饰的弹性乳清体来增强阿尔本达的抗癌活性
Rofida Albash1, Hassan M E Azzazy2, Shaimaa Mosallam3
1Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt.
Frontiers in pharmacology
|September 22, 2025
概括
抗虫药物阿尔本达 (Albendazole) 被配制成氨酸弹性体,以增强其抗癌性质. 这种新型药物输送系统在临床前模型中显示出显著的瘤减少,这表明癌症治疗的潜力.
科学领域:
- 纳米技术在药物输送中的应用
- 制药科学 制药科学
- 在瘤学瘤学.
背景情况:
- 阿尔本达 (Albendazole,ALB) 是一种成熟的杀虫剂,目前正在研究用于癌症治疗.
- 基于氨酸 (SA) 的弹性乳清体 (EC) 被开发来提高ALB的抗癌疗效.
研究的目的:
- 为了制定和表征SA-EC-ALB纳米颗粒用于增强抗癌活性.
- 评估新型药物输送系统的in-silico和in-vivo性能.
主要方法:
- 使用薄膜水化和超声波的SA-EC-ALB的配方.
- 使用D-最佳实验设计的优化,使用不同的SAA和陶类型.
- 捕获效率 (EE%),粒子大小 (PS) 和多分散率指数 (PDI) 的表征.
主要成果:
- 优化的SA-EC-ALB配方实现了92.03%的EE%和312.05 nm PS.
- 在体分析证实了ALB和体组件之间的强烈相互作用.
- 活体内研究显示,小鼠的固体埃里希瘤体积显著减少.
结论:
- 将阿尔本达装入SA-EC纳米颗粒中可以增强其抗癌潜力.
- 在癌症治疗中,SA-EC-ALB 是一个有前途的纳米载体.
相关概念视频
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Drugs for Treatment of Ulcerative Colitis in IBD
463
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
463


